Hepatitis B surface antigen inhibits MICA and MICB expression via induction of cellular miRNAs in hepatocellular carcinoma cells

Carcinogenesis

Volumn 35, Issue 1, 2014, Pages 155-163

  Wu, Jianmin ^a   Zhang, Xue Jiao ^a   Shi, Ke Qing ^a   Chen, Yong Ping ^a   Ren, Yong Feng ^a   Song, Yi Jiang ^a   Li, Guiling ^a   Xue, Yong Feng ^a   Fang, Yu Xiao ^a   Deng, Zhu Jun ^a   Xu, Xiaoling ^a   Gao, Jimin ^a   Tang, Kai Fu ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HLA A ANTIGEN; HLA B ANTIGEN; MICRORNA; MICRORNA 107; MICRORNA 15B; MICRORNA 16; MICRORNA 17; MICRORNA 20A; MICRORNA 29A; MICRORNA 29B; MICRORNA 29C; MICRORNA 373; NATURAL KILLER CELL RECEPTOR NKG2D; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANTIGEN EXPRESSION; ARTICLE; CARCINOMA CELL; CELL ACTIVITY; CONTROLLED STUDY; CYTOLYSIS; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSURVEILLANCE; LIVER CELL CARCINOMA; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; UPREGULATION;

CARCINOMA, HEPATOCELLULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LIVER NEOPLASMS; MICRORNAS;

EID: 84891347981     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt268     Document Type: Article

References (53)

1. Ganem,D. et al. (1987) The molecular biology of the hepatitis B viruses. Annu. Rev. Biochem., 56, 651-693.
2. Moolla,N. et al. (2002) Regulatory elements of hepatitis B virus transcription. J. Viral Hepat., 9, 323-331.
3. Rehermann,B. et al. (2005) Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol., 5, 215-229.
4. Guidotti,L.G. et al. (2006) Immunobiology and pathogenesis of viral hepatitis. Annu. Rev. Pathol., 1, 23-61.
5. Chai,N. et al. (2008) Properties of subviral particles of hepatitis B virus. J. Virol., 82, 7812-7817.
6. Chisari,F.V. et al. (2010) Pathogenesis of hepatitis B virus infection. Pathol. Biol. (Paris), 58, 258-266.
7. Lavanchy,D. (2005) Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J. Clin. Virol., 34 (suppl. 1), S1-S3.
8. Tseng,T.C. et al. (2012) High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology, 142, 1140-1149.e3; quiz e13.
9. Yuen,M.F. et al. (2008) HBsAg seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology, 135, 1192-1199.
10. Wang,Y. et al. (2004) HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice. Hepatology, 39, 318-324.
11. Raulet,D.H. (2003) Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol., 3, 781-790.
12. González,S. et al. (2006) Immunobiology of human NKG2D and its ligands. Curr. Top. Microbiol. Immunol., 298, 121-138.
13. Lanier,L.L. (2008) Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol., 9, 495-502.
14. Bauer,S. et al. (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science, 285, 727-729.
15. Groh,V. et al. (1999) Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl Acad. Sci. USA, 96, 6879-6884.
16. Swann,J.B. et al. (2007) Immune surveillance of tumors. J. Clin. Invest., 117, 1137-1146.
17. Hasan,M. et al. (2005) Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J. Virol., 79, 2920-2930.
18. Cerboni,C. et al. (2007) Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J. Gen. Virol., 88(Pt 1), 242-250.
19. Sène,D. et al. (2010) Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines. PLoS Pathog., 6, e1001184.
20. Tang,K.F. et al. (2009) Inhibition of hepatitis B virus replication by small interference RNA induces expression of MICA in HepG2.2.15 cells. Med. Microbiol. Immunol., 198, 27-32.
21. Ebert,M.S. et al. (2012) Roles for microRNAs in conferring robustness to biological processes. Cell, 149, 515-524.
22. Mendell,J.T. et al. (2012) MicroRNAs in stress signaling and human disease. Cell, 148, 1172-1187.
23. Lim,L.P. et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433, 769-773.
24. Stern-Ginossar,N. et al. (2008) Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat. Immunol., 9, 1065-1073.
25. Yadav,D. et al. (2009) Cutting edge: down-regulation of MHC class I-related chain A on tumor cells by IFN-gamma-induced microRNA. J. Immunol., 182, 39-43.
26. Nachmani,D. et al. (2010) The human cytomegalovirus microRNA miRUL112 acts synergistically with a cellular microRNA to escape immune elimination. Nat. Immunol., 11, 806-813.
27. Tang,K.F. et al. (2008) Decreased Dicer expression elicits DNA damage and up-regulation of MICA and MICB. J. Cell Biol., 182, 233-239.
28. Jiang,J. et al. (2008) Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin. Cancer Res., 14, 419-427.
29. Ladeiro,Y. et al. (2008) MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology, 47, 1955-1963.
30. Ura,S. et al. (2009) Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology, 49, 1098-1112.
31. Wang,Y. et al. (2010) Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. J. Hepatol., 53, 57-66.
32. Gao,P. et al. (2011) Deregulation of microRNA expression occurs early and accumulates in early stages of HBV-associated multistep hepatocarcinogenesis. J. Hepatol., 54, 1177-1184.
33. Kong,G. et al. (2011) Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS One, 6, e19518.
34. Sells,M.A. et al. (1987) Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl Acad. Sci. USA, 84, 1005-1009.
35. Jinushi,M. et al. (2003) Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int. J. Cancer, 104, 354-361.
36. Tam,Y.K. et al. (1999) Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy. Hum. Gene Ther., 10, 1359-1373.
37. Zamore,P.D. et al. (2000) RNAi: double-stranded RNA directs the ATPdependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell, 101, 25-33.
38. Chen,Y. et al. (2006) Hepatitis B virus down-regulates expressions of MHC class I molecules on hepatoplastoma cell line. Cell. Mol. Immunol., 3, 373-378.
39. Guo,H. et al. (2011) MicroRNAs-372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B. Hepatology, 54, 808-819.
40. Chisari,F.V. et al. (1989) Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell, 59, 1145-1156.
41. Nakamoto,Y. et al. (1998) Immune pathogenesis of hepatocellular carcinoma. J. Exp. Med., 188, 341-350.
42. Wong,D.K. et al. (2006) Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma. J. Hepatol., 45, 553-559.
43. Xu,X. et al. (2013) Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. J. Clin. Invest., 123, 630-645.
44. Wei,X. et al. (2013) miR-101 is down-regulated by the hepatitis B virus × protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A. Cell. Signal., 25, 439-446.
45. Wu,G. et al. (2011) Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro. Br. J. Cancer, 105, 146-153.
46. Huang,Q. et al. (2008) The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat. Cell Biol., 10, 202-210.
47. Fabbri,M. et al. (2007) MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl Acad. Sci. USA, 104, 15805-15810.
48. Garzon,R. et al. (2009) MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood, 113, 6411-6418.
49. Feinberg,A.P. et al. (2006) The epigenetic progenitor origin of human cancer. Nat. Rev. Genet., 7, 21-33.
50. Ma,F. et al. (2011) The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ. Nat. Immunol., 12, 861-869.
51. Bandyopadhyay,S. et al. (2011) Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture. J. Infect. Dis., 203, 1753-1762.
52. An,F. et al. (2012) miR-15b and miR-16 regulate TNF mediated hepatocyte apoptosis via BCL2 in acute liver failure. Apoptosis, 17, 702-716.
53. Chen,H.Y. et al. (2012) miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res., 72, 3631-3641.